Overview
- Peptide CTAENTLFYVKES, corresponding to amino acid residues 270-282 of human P2Y12 receptor (Accession Q9H244). 3rd extracellular loop.
- Cell surface detection of P2Y12 by direct flow cytometry in live intact mouse BV-2 microglia cells:___ Cells.
___ Cells + Rabbit IgG isotype control-APC (#RIC-001-APC).
___ Cells + Anti-P2Y12 Receptor (extracellular)-APC Antibody (#APR-020-APC), (2.5µg). - Cell surface detection of P2Y12 by direct flow cytometry in live intact human MEG-01 megakaryocytic cells:___ Cells.
___ Cells + Rabbit IgG isotype control-APC (#RIC-001-APC).
___ Cells + Anti-P2Y12 Receptor (extracellular)-APC Antibody (#APR-020-APC), (2.5µg). - Cell surface multicolor flow cytometry analysis of live intact mouse BV-2 microglia cells with P2Y12 and TREM2:BV-2 cells were labeled with Anti-P2Y12 Receptor (extracellular)-APC Antibody (#APR-020-APC), (5µg) and with Anti-TREM2 (extracellular)-PE Antibody (#ANR-018-PE), (5µg).
The P2Y receptors belong to the G-protein coupled receptor superfamily. They mediate the actions of the extracellular nucleotides (ATP, ADP, UTP and UDPA). Eight functional mammalian P2Y receptors have been described: P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and the UDP-glucose receptor, now renamed P2Y141-3.
The P2Y12 receptor is co-expressed with the P2Y1 receptor on platelets leading to shape change, aggregation, and rise in intracellular Ca2+ upon activation.
The only other expression of P2Y12 was found in brain, according to results of reverse transcription-polymerase chain reaction and northern blotting4. The P2Y12 receptor has become a target for potential therapeutic drugs for the treatment of thromboembolism and other clotting disorders4.